NCT06336629View on ClinicalTrials.gov

A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

July 10, 2024

Study Completion Date

July 10, 2024

Conditions
Acne Vulgaris
Interventions
DRUG

Winlevi (clascoterone) 1% & Duac gel

Participants will use Winlevi (clascoterone) 1% and Duac gel as per label

Trial Locations (1)

40217

Skin Sciences, PLLC, Louisville

All Listed Sponsors
lead

Sun Pharmaceutical Industries Limited

INDUSTRY

NCT06336629 - A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne | Biotech Hunter | Biotech Hunter